LPL Financial LLC Boosts Investment in QuidelOrtho Co., Expanding Healthcare Portfolio
June 1, 2023
☀️Trending News
QUIDELORTHO ($NASDAQ:QDEL): LPL Financial LLC has recently taken a strategic move to expand its healthcare investments portfolio by increasing its stake in Quidel Ortho Co. Quidel Ortho Co is a biomedical technology company that develops, manufactures and markets in vitro diagnostics for detecting various medical conditions. The company’s products are used in clinics, laboratories and point-of-care settings to provide accurate and timely diagnostic information. This move demonstrates LPL Financial’s commitment to the advancement of healthcare services and technologies and its goal of delivering the highest quality of healthcare solutions. The company’s products are based on proprietary technologies used for the development of innovative systems for the detection of infectious diseases, cancer, cardiovascular diseases and other health conditions. Quidel Ortho Co’s products include a wide range of tests for the detection of diseases such as HIV, hepatitis C, Chlamydia, and gonorrhea.
The company also provides a range of products for the diagnosis of other medical conditions such as food allergies, fatty liver disease, and kidney stones. This new investment by LPL Financial signals the company’s intention to remain at the forefront of healthcare investments and its commitment to providing innovative healthcare solutions. With this new investment, LPL Financial hopes to not only expand its healthcare investments portfolio but also to support the development of groundbreaking medical technology that will help improve patient care.
Price History
On Tuesday, QUIDELORTHO CORP was the talk of the town as LPL Financial LLC increased its investment in the company. This move is part of LPL Financial’s strategy to expand its healthcare portfolio. This expansion served to benefit QUIDELORTHO CORP stock, which opened at $85.4 and closed at $86.5, representing a 1.1% increase from the last closing price of $85.5. This increase indicates that the market values QUIDELORTHO CORP highly and believes that LPL Financial’s increased investment will be beneficial for the company. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Quidelortho Corp. More…
| Total Revenues | Net Income | Net Margin |
| 3.11k | 117.6 | 7.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Quidelortho Corp. More…
| Operations | Investing | Financing |
| 573.3 | -1.69k | 195.8 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Quidelortho Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 8.79k | 3.79k | 75.03 |
Key Ratios Snapshot
Some of the financial key ratios for Quidelortho Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 76.9% | 57.6% | 9.4% |
| FCF Margin | ROE | ROA |
| 12.5% | 3.7% | 2.1% |
Analysis
GoodWhale recently conducted an analysis of QUIDELORTHO CORP‘s wellbeing. After examining a variety of financial and business aspects, we have assigned it a high risk rating. Upon further inspection of the company’s income sheet and balance sheet, we have identified two risk warnings. At GoodWhale, we know how important it is to make informed decisions when it comes to investing. That’s why we have developed a comprehensive tool that enables you to make the best possible assessment of investments in terms of risk. By registering on goodwhale.com, you can access our findings and have confidence that your investments are sound. More…
Peers
Quidel Corporation is a leading provider of diagnostic healthcare solutions serving both the professional and consumer markets. The company manufactures and sells a broad range of diagnostic products, including immunoassays, molecular diagnostics, and infectious disease tests. Quidel’s products are used in hospitals, physician offices, clinics, and commercial laboratories, as well as at-home for self-testing. Quidel has a strong portfolio of products and a long history of providing high-quality diagnostics.
However, the company faces competition from a number of other companies, including LifePoint Inc, Bloom Health Partners Inc, and Talis Biomedical Corp.
– LifePoint Inc ($OTCPK:LFPI)
LifePoint Inc is a company that provides healthcare services. It has a market cap of 10.21k as of 2022 and a Return on Equity of 8.83%. The company has a strong ROE, which indicates that it is efficient in using its assets to generate profits. The company is doing well financially and is expected to continue to grow in the future.
– Bloom Health Partners Inc ($OTCPK:BLMHF)
The company’s market cap is 2.86M as of 2022. The company’s ROE is 26.8%. The company’s main products and services are health insurance, health care, and benefits administration. Health insurance coverage is provided to individuals, families, and businesses through a variety of plans. Health care services are delivered through a network of providers. Benefits administration services are provided to employers and employees.
– Talis Biomedical Corp ($NASDAQ:TLIS)
Talis Biomedical Corp is a medical technology company that develops and commercializes products based on its proprietary technology Platform for the early detection of infectious diseases. The Platform is designed to provide rapid, sensitive, and accurate detection of a wide range of infectious diseases. Talis Biomedical’s products are based on its proprietary platform technology, which is designed to provide rapid, sensitive, and accurate detection of a wide range of infectious diseases. Talis Biomedical’s products are intended for use in a variety of settings, including hospital emergency departments, primary care offices, and home health settings. Talis Biomedical’s products are currently in development and have not been cleared for commercial sale by the U.S. Food and Drug Administration.
Summary
Quidel Ortho Corp saw an increase in investment from LPL Financial LLC recently. This strategic move is part of an increased focus on Quidel Ortho’s healthcare portfolio. Quidel Ortho Corp is a medical equipment and diagnostics manufacturer specializing in testing and measuring equipment for the clinical and hospital market. The company’s products are used to detect and diagnose medical conditions, with the aim of providing effective treatment.
This increased investment from LPL Financial LLC means that Quidel Ortho Corp is now better positioned to capitalize on the growth opportunities within the healthcare industry. Quidel Ortho is expected to benefit from increased revenue, higher shares prices, and better reach into new markets. In turn, this can bring greater returns for investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
